The researcher will study how the tumour environment influences the response to Pan-KRAS inhibitors, one of the most promising therapeutic strategies against pancreatic ductal adenocarcinoma.
Read moreLa investigación del Centro de Investigación del Cáncer, liderada por Sandra Blanco, explora el potencial del epitranscriptoma para desarrollar nuevos fármacos capaces de mejorar la respuesta a lo...
Read moreThe project aims to determine how genetic alterations affecting the BAF complex, and the epigenetic changes they trigger, contribute to treatment resistance and disease progression.
Read morePublished in Nature, the team led by Dr. Toni Gabaldón used the MareNostrum supercomputer to reconstruct the genetic origin of the last common ancestor of all eukaryotes—the cellular lineage to whi...
Read moreThe University of Barcelona Parc Científic de Barcelona (PCB-UB) broke its investment record in 2025, with a total of €229.7 million raised by the companies in its ecosystem. Start-ups, spin-offs a...
Read moreLa investigación ha analizado la seguridad y el comportamiento en el organismo de una terapia experimental dirigida a reducir los niveles de amonio en sangre
Read moreYeates is the inventor of protein nanoparticles that assemble themselves, much like ‘Lego’ bricks. They are used to visualise very small proteins that are targets for anti-cancer drugs.
Read moreThe HMarBCN -CNIO Cancer Immunotherapy Clinical Research Unit has just received funding from the Deutsche José Carreras Leukämie Stiftung for a project aimed at modifying T cells directly within the...
Read moreGate2Brain signs a strategic partnership with Shilpa Biocare, including a €7 million investment for a 30.4% equity stake in the company.
Read moreUn estudio liderado por hematólogos del Cancer Center Clínica Universidad de Navarra ha analizado este tumor célula a célula y ha descubierto que, cuando evoluciona, las defensas presentan menor c...
Read moreUn estudio del Instituto de Neurociencias (CSIC-UMH) muestra en modelos animales cómo este compuesto reduce el tamaño y la toxicidad de las sustancias que generan esta enfermedad
Read moreThe study, published in Nature Communications, develops a new cellular model that reproduces the progression of NF1-associated tumours and enables the identification of new therapeutic opportunities.
Read more